Single-agent daratumumab for refractory POEMS syndrome

Han Wei Tiew; Venkata Sreekanth Sampath; Christian Aledia Gallardo; Dheepa Christopher; Stephrene Seok Wei Chan; Shiun Woei Wong; Allison Ching Yee Tso; Lian King Lee; Bingwen Eugene Fan

doi:10.1002/ajh.26517

Single-agent daratumumab for refractory POEMS syndrome

Am J Hematol. 2022 Jun 1;97(6):E189-E191. doi: 10.1002/ajh.26517. Epub 2022 Mar 11.

Authors

Han Wei Tiew¹, Venkata Sreekanth Sampath^{1

2

3

4}, Christian Aledia Gallardo¹, Dheepa Christopher^{1

2

3

4}, Stephrene Seok Wei Chan^{1

2

3

4}, Shiun Woei Wong^{3

4

5}, Allison Ching Yee Tso^{1

2

3

4}, Lian King Lee^{1

2

3

4}, Bingwen Eugene Fan^{1

2

3

4}

Affiliations

¹ Department of Haematology, Tan Tock Seng Hospital, Singapore.
² Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore.
³ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
⁴ Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
⁵ Department of Cardiology, Tan Tock Seng Hospital, Singapore.

PMID: 35253931
DOI: 10.1002/ajh.26517

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Humans
Multiple Myeloma*
POEMS Syndrome* / drug therapy

Substances

Antibodies, Monoclonal
daratumumab